Ophthalmogenetics and Gene Therapy

Gene therapy is moreover in a situation to manage essential open-edge glaucoma (POAG) in creature models, and research show it is monetarily reasonable. Genes may furthermore be conveyed into cells in vitro or in vivo making utilization of viral or non-viral vectors. Ongoing specialized advances have prompted the showing of the sub-atomic premise of a scope of visual sicknesses.

  • Genetics of Myopia Development
  • Retinoblastoma

Related Conference of Ophthalmogenetics and Gene Therapy

March 02-03, 2020

5thGlobal Pediatric Ophthalmology Congress

Rome, Italy
June 28-30 2020

Diamond and Carbon 2020

April 13-14, 2020

World Congress on Ophthalmology & Optometry

London, UK
April 13-14, 2020

34th Global Ophthalmologists Annual meeting

London, UK
August 07-08, 2020

4th International Conference on Ophthalmology

Osaka, Japan
September 28-29, 2020

4th Annual Conference on Orthopedics, Rheumatology and Osteoporosis

Singapore City, Singapore
October 19-20, 2020

19th Asia Pacific Ophthalmologists Annual Meeting

| Singapore
October 22-23, 2020

World Congress on Ophthalmology and Optometry

Tokyo, Japan
October 28-29, 2020

30th World Congress on Ophthalmology and Optometry

Amsterdam, Netherlands
November 12-13, 2020

European Conference on Ophthalmology & Eye care

Budapest, Hungary
November 23-24, 2020

3rd World Congress on Eye and Vision

Istanbul, Turkey
November 23-24, 2020

3rd World Eye and Vision Congress

Istanbul, Turkey
November 23-24, 2020

34th European Ophthalmology Congress

Rome, Italy

Ophthalmogenetics and Gene Therapy Conference Speakers

Recommended Sessions

Related Journals

Are you interested in